UNITED STATES NEWS

Next on FDA’s agenda: Booster shots of Moderna, J&J vaccines

Oct 12, 2021, 7:33 AM | Updated: Oct 13, 2021, 8:49 am
FILE - In this May 19, 2021, file photo, a licensed practical nurse draws a Moderna COVID-19 vaccin...

FILE - In this May 19, 2021, file photo, a licensed practical nurse draws a Moderna COVID-19 vaccine into a syringe at a mass vaccination clinic at Gillette Stadium in Foxborough, Mass. Starting Thursday, Oct. 14, 2021, the Food and Drug Administration convenes its independent advisers for the first stage in the process of deciding whether extra shots of Moderna or Johnson & Johnson vaccines should be dispensed and, if so, who should get them and when. (AP Photo/Steven Senne, File)

(AP Photo/Steven Senne, File)

WASHINGTON (AP) — With many Americans who got Pfizer vaccinations already rolling up their sleeves for a booster shot, millions of others who received the Moderna or Johnson & Johnson vaccine wait anxiously to learn when it’s their turn.

Federal regulators begin tackling that question this week.

On Thursday and Friday, the Food and Drug Administration convenes its independent advisers for the first stage in the process of deciding whether extra doses of the two vaccines should be dispensed and, if so, who should get them and when. The final go-ahead is not expected for at least another week.

After the FDA advisers give their recommendation, the agency itself will make a decision on whether to authorize boosters. Then next week, a panel convened by the Centers for Disease Control and Prevention will offer more specifics on who should get them. Its decision is subject to approval by the CDC director.

The process is meant to bolster public confidence in the vaccines. But it has already led to conflicts among experts and agencies — and documents the FDA released Tuesday suggest this week’s decisions will be equally difficult.

In one earlier vaccine dispute, the CDC’s advisory panel last month backed Pfizer boosters at the six-month point for older Americans, nursing home residents and people with underlying health problems. But CDC Director Dr. Rochelle Walensky overruled her advisers and decided boosters should also be offered to those with high-risk jobs such as teachers and health care workers, adding tens of millions more Americans to the list.

Some health experts fear the back-and-forth deliberations are muddling the public effort to persuade the unvaccinated to get their first shots. They worry that the talk of boosters will lead people to wrongly doubt the effectiveness of the vaccines in the first place.

When the FDA’s panel meets to review the Moderna and J&J vaccines, experts will discuss whether a third Moderna shot should contain just half the original dose and what’s the best timing for a second shot of the single-dose J&J vaccine.

The panel will also look into the safety and effectiveness of mixing-and-matching different brands of vaccine, something regulators have not endorsed so far.

An estimated 103 million Americans are fully vaccinated with Pfizer’s formula, 69 million with Moderna’s and 15 million with J&J’s, according to the CDC. Regulators took up the question of Pfizer boosters first because the company submitted its data ahead of the other vaccine makers.

Tim Anderson, a U.S. history teacher at a high school outside Louisville, Kentucky, already had his two Moderna shots months before he came down with COVID-19 in August. While his symptoms hit him “like a sledgehammer,” he is convinced that the inoculation saved him and his girlfriend from the more severe effects of the disease.

The two are now awaiting clearance of a Moderna booster shot.

“Until we can build up enough immunity within our own self and, you know, as a group of humans, I’m willing to do what I need to do,” Anderson, 58, said.

The FDA meetings come as U.S. vaccinations have climbed back above 1 million per day on average, an increase of more than 50% over the past two weeks. The rise has been driven mainly by Pfizer boosters and employer vaccine mandates.

While the FDA and CDC so far have endorsed Pfizer boosters for specific groups only, Biden administration officials, including Dr. Anthony Fauci, have suggested that extra shots will eventually be recommended for most Americans.

In a new review of Moderna’s data, the FDA did not indicate Tuesday if it was leaning toward clearing the company’s booster. It said vaccines used in the U.S. still provide protection, and it raised questions about some of Moderna’s data.

The two initial Moderna shots contain 100 micrograms of vaccine each. But the drugmaker says 50 micrograms ought to be enough for a booster for healthy people.

A company study of 344 people gave them a 50-microgram shot six months after their second dose, and levels of virus-fighting antibodies jumped. Moderna said the booster even triggered a 42-fold rise in antibodies able to target the extra-contagious delta variant.

Side effects were similar to the fevers and aches that Moderna recipients commonly experience after their second regular shot, the company said.

As for people who got the J&J vaccine, the company submitted data to the FDA for different options: a booster shot at two months or at six months. The company said in its FDA submission that a six-month booster is recommended but that a second dose could be given at two months in some situations.

J&J released data in September showing that a booster given at two months provided 94% protection against moderate-to-severe COVID-19 infection. The company has not disclosed patient data on a six-month booster, but early measures of virus-fighting antibodies suggest it provides even higher protection.

Even without a booster, J&J says, its vaccine remains about 80% effective at preventing COVID-19 hospitalizations in the U.S.

Scientists emphasize that all three vaccines used in the U.S. still offer strong protection against severe disease and death from COVID-19. The issue is how quickly, and how much, protection against milder infection may wane.

In one recent study, researchers compared about 14,000 people who had gotten their first Moderna dose a year ago with 11,000 vaccinated eight months ago. As the delta variant surged in July and August, the more recently vaccinated group had a 36% lower rate of “breakthrough” infections compared with those vaccinated longer ago.

___

AP Writer Bobby Caina Calvan contributed to this story from New York.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.

Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.


              FILE - In this May 21, 2021, file photo, two people wait to receive the Moderna COVID-19 vaccine at Providence Edwards Lifesciences vaccination site in Santa Ana, Calif. Starting Thursday, Oct. 14, 2021, the Food and Drug Administration convenes its independent advisers for the first stage in the process of deciding whether extra shots of  Moderna or Johnson & Johnson vaccines should be dispensed and, if so, who should get them and when. (AP Photo/Jae C. Hong, File)
            
              FILE - In this May 19, 2021, file photo, a licensed practical nurse draws a Moderna COVID-19 vaccine into a syringe at a mass vaccination clinic at Gillette Stadium in Foxborough, Mass. Starting Thursday, Oct. 14, 2021, the Food and Drug Administration convenes its independent advisers for the first stage in the process of deciding whether extra shots of  Moderna or Johnson & Johnson vaccines should be dispensed and, if so, who should get them and when. (AP Photo/Steven Senne, File)

United States News

FILE - Singer Celine Dion performs during her Courage tour in Quebec City on Sept. 18, 2019. Dion h...
Associated Press

Celine Dion cancels shows because of stiff person syndrome

Celine Dion has put a halt on all performing after being diagnosed with a rare neurological disorder. In an emotional video messages posted in French and English on Thursday on Instagram, Dion said stiff person syndrome was causing spasms that affect her ability to walk and sing. “Unfortunately, the spasms affect every aspect of my […]
2 days ago
Supporters hold up signs reading "Bring Brittney Home" during a rally to support the release of det...
KTAR.com

Arizona politicians react to news of Phoenix WNBA star Brittney Griner’s release

News of Phoenix Mercury star Brittney Griner’s release from a Russian prison was welcomed by political leaders in Arizona.
2 days ago
(AP Photo/Eric Gay, File)...
Associated Press

House sends bill protecting same-sex, interracial marriages to Biden

The bill requires all states to recognize legal marriages regardless of “sex, race, ethnicity or national origin.”
2 days ago
House Minority Leader Kevin McCarthy of Calif., departs after speak during a Congressional Gold Med...
Associated Press

Congress set to rescind COVID-19 vaccine mandate for troops

WASHINGTON (AP) — The COVID-19 vaccine mandate for members of the U.S. military would be rescinded under the annual defense bill heading for a vote this week in Congress, ending a directive that helped ensure the vast majority of troops were vaccinated but also raised concerns that it harmed recruitment and retention. Republicans, emboldened by […]
3 days ago
FILE - Light illuminates part of the Supreme Court building at dusk on Capitol Hill in Washington, ...
Associated Press

Justices skeptical of elections case that could alter voting

WASHINGTON (AP) — At least six Supreme Court justices sound skeptical of making a broad ruling that would leave state legislatures virtually unchecked when making rules for elections for Congress and the presidency. In arguments Wednesday, both liberal and conservative members of the high court appeared to take issue with the main thrust of a […]
3 days ago
Blue Bunny and Halo Top brand ice cream products are seen in Englewood, N.J., The Italian confectio...
Associated Press

Ferrero buys Blue Bunny ice cream maker Wells Enterprises

Italian confectioner Ferrero said Wednesday it is acquiring Wells Enterprises, one of the largest U.S. ice cream makers, in a deal that will broaden both companies’ offerings. Wells, a 100-year-old family-owned company based in Le Mars, Iowa, makes Blue Bunny, Halo Top and other brands. It employs 4,000 people and produces more than 200 million […]
3 days ago

Sponsored Articles

...
Day & Night Air Conditioning, Heating and Plumbing

Prep the plumbing in your home just in time for the holidays

With the holidays approaching, it's important to know when your home is in need of heating and plumbing updates before more guests start to come around.
(Desert Institute for Spine Care photo)...
DESERT INSTITUTE FOR SPINE CARE

Why DISC is world renowned for back and neck pain treatments

Fifty percent of Americans and 90% of people at least 50 years old have some level of degenerative disc disease.
...
Quantum Fiber

How high-speed fiber internet can improve everyday life

Quantum Fiber supplies unlimited data with speeds up to 940 mbps, enough to share 4K videos with coworkers 20 times faster than a cable.
Next on FDA’s agenda: Booster shots of Moderna, J&J vaccines